Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 40.77
-0.22 (-0.54%)
Aug 31, 2026, 4:10 PM AEST
Ansell Revenue
In the fiscal year ending June 30, 2026, Ansell had annual revenue of $2.14B USD with 6.83% growth. Ansell had revenue of $1.11B in the half year ending June 30, 2026, with 33.46% growth.
Revenue
$2.14B
Revenue Growth
+6.83%
P/S Ratio
1.84
Revenue / Employee
$142.68K
Employees
15,000
Market Cap
5.69B AUD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.14B | 136.90M | 6.83% |
| Jun 30, 2025 | 2.00B | 384.00M | 23.71% |
| Jun 30, 2024 | 1.62B | -35.80M | -2.16% |
| Jun 30, 2023 | 1.66B | -297.00M | -15.21% |
| Jun 30, 2022 | 1.95B | -74.80M | -3.69% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.58B |
| Sonic Healthcare | 10.87B |
| Sigma Healthcare | 10.83B |
| Cochlear | 2.35B |
| Telix Pharmaceuticals | 1.29B |
| Pro Medicus | 261.69M |
| Mesoblast | 173.82M |
Ansell News
- 7 days ago - Ansell Earnings Call Transcript: H2 2026 - Transcripts
- 7 days ago - Ansell Earnings release: H2 2026 - Filings
- 7 days ago - Ansell Slides: H2 2026 - Filings
- 7 days ago - Ansell Annual report: H2 2026 - Filings
- 7 months ago - Ansell Earnings Call Transcript: H1 2026 - Transcripts
- 7 months ago - Ansell Quarterly report: H1 2026 - Filings
- 7 months ago - Ansell Slides: H1 2026 - Filings
- 7 months ago - Ansell Earnings release: H1 2026 - Filings